A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings
Clinical trial NCT04940039 · COMPLETED
Trial details
- NCT number
- NCT04940039
- Sponsor
- Janssen-Cilag International NV
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-22
- Primary completion
- 2024-04-16
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.